The WHO called into question the extent that asymptomatic people are spreading COVID-19, launching a global debate, The Hill reports.

Coronavirus communicators are finally getting to know an inevitable ally: the influencer. To reach vulnerable communities at the local level, the NoCovid project—the National Organizing Coalition On Virus Information Distribution—enlists celebrities and scientists alike to…

One of the biggest questions around an eventual COVID-19 vaccine: Will it be equitably deployed throughout the world?   Inspired by previous efforts around Ebola and pneumococcal vaccines,

Germany’s early, strong push on contact tracing may be helping the country keep COVID-19 deaths—10 per 100,000 people—comparatively low. The US has seen almost 3 times as many deaths; France and Britain, more than 4 and 5½ times, respectively. Germany’s approach—…

For African scientists, the coronavirus pandemic may offer a rare opportunity to fill the research funding gap that has long hindered scientific pursuits on the continent.

Much of the current COVID-19 discussion across the US focuses on choreographing a transition from what has been called the “hammer” of lockdowns to the “dance” of a carefully staged easing of certain restrictions.   

As the US grapples with the need for “an army” of 100,000 contact tracers, a free online course aims to get Americans trained for the task. Before the pandemic, just 2,200 contact tracers were working in the US, The Washington post.

Nearly all people exposed to COVID-19 in a New York study developed antibodies to the virus—even those who showed just mild symptoms, according to a New York Times analysis of a preprint study. Based on antibody tests on the first set of donors for a convalescent plasma…

The rising popularity of an unproven COVID-19 remedy in Africa is also raising concern about malaria drug resistance. Developed in Madagascar, the tonic’s main ingredient—Artemisia annua—is the foundation of artemisinin-based combination therapies, the go-to…

Well before COVID-19, the built environment was informed by the legacy of disease pandemics.